CDC warns of COVID "rebound" after taking Paxlovid, says drug still beneficial

CDC warns of COVID-19 "rebound" after taking Paxlovid, but says drug still beneficial

May 30, 2022 by CBS News

Key Facts

  • CBS Evening News May 30, 2022 / 7:05 PM / CBS News CDC warns of COVID "rebound" after Paxlovid CDC warns of COVID-19 "rebound" after Pfizer pill Paxlovid 02:07 As COVID-19 cases continue to rise, Paxlovid is being prescribed to try to keep high-risk patients out of the hospital.
  • But the Centers for Disease Control and Prevention is warning of potential "COVID-19 rebound" after a five-day course of the treatment.
  • There is currently no evidence that additional treatment is needed, according to the CDC, and Pfizer, the maker of Paxlovid, is not changing its dosage guidelines.
  • Pfizer said it is currently seeing a rebound rate of about 2%, but is continuing to monitor patients Infectious disease expert Dr. David Ho tested positive for COVID-19 after attending a conference on the virus.

Click To Read Full Article


This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at Write to © 2021 Kwhen Inc.

Was this content valuable for you?